Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 4Neoplasms 3Small Cell Lung Carcinoma 2Pneumonia 2Lymphoma 2Tuberculosis 1Sarcoidosis 1Pulmonary Disease, Chronic Obstructive 1Precancerous Conditions 1Lung Diseases, Interstitial 1Leukemia 1Chromosome Aberrations 1Carcinogenesis 1

Interventions

Surveys and Questionnaires 114Exercise 103Blood Specimen Collection 99Radiotherapy 67Gemcitabine 64Bevacizumab 57Standard of Care 56Cisplatin 55Cyclophosphamide 51Capecitabine 50Carboplatin 49Docetaxel 47pembrolizumab 46Dexamethasone 46Paclitaxel 45Interviews as Topic 43Oxaliplatin 40Magnetic Resonance Spectroscopy 39Fluorouracil 37Methods 36Irinotecan 36Therapeutics 33Drug Therapy 33Radiosurgery 31Nivolumab 30Erlotinib Hydrochloride 27Educational Status 26Everolimus 24Leucovorin 23Control Groups 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Neoplasms × Bronchoalveolar Lavage × Clear all
NCT03388580 2018-01-04

Predictors for Bronchoalveolar Lavage (BAL) Recovery Rate Derived From Quantified Computed Tomography (qCT)

Universitätsmedizin Mannheim

Completed
33 enrolled

Neoplasms, Pneumonia, Lung Diseases, Interstitial

NCT02874729 2016-11-25

Assay Development for Cancer Biomarkers

King's College London

Unknown
400 enrolled
Tumor-Agnostic

Neoplasms

NCT00248443 2011-02-18

Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
206 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡